DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Imaging in cancer diagnosis and response assessment

Essential points for quick revision.

Synopsis

Choose cancer imaging according to the clinical question, sequence diagnosis and staging safely, interpret response and treatment effects, and avoid false precision from incidental or equivocal findings.

  • Imaging answers a defined question: detect a lesion, characterise local anatomy, stage spread, guide biopsy, plan treatment, assess complications or measure response.
  • Ultrasound, CT, MRI, PET-CT, plain radiography and nuclear medicine have complementary strengths; no modality is a universal gold standard for all cancers.
  • Use the tumour-specific first-line staging pathway and image enough anatomy to change management without repeating recent adequate studies.

Key red flags

Imaging emergency

New cord, brain, airway, vascular, bowel or urinary compromise requires same-day targeted imaging and acute specialist action.

Investigation priorities

01
Contrast-enhanced CTFirst step

Stage thoracic, abdominal and pelvic anatomy rapidly and assess many acute complications.

Management branches

SelectMatch modality to the decision

Cancer is suspected or confirmed and imaging is required.

  1. State whether the question is diagnosis, local staging, distant staging, biopsy access, emergency complication or treatment response.
  2. Use the tumour-specific recommended modality and review recent images to avoid duplication, radiation and delay.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom